| Product Code: ETC7551898 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India prescription drugs market import shipment experienced consistent growth from 2020 to 2024, with a CAGR of 5.4%. The growth rate accelerated in the most recent period, showing a positive momentum. Overall, the market expanded steadily, indicating a promising trend for the future.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Prescription Drugs Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Prescription Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 India Prescription Drugs Market - Industry Life Cycle |
3.4 India Prescription Drugs Market - Porter's Five Forces |
3.5 India Prescription Drugs Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 India Prescription Drugs Market Revenues & Volume Share, By Therapy Area, 2021 & 2031F |
3.7 India Prescription Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 India Prescription Drugs Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 India Prescription Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 India Prescription Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing healthcare expenditure in India |
4.2.2 Growing prevalence of chronic diseases requiring long-term medication |
4.2.3 Government initiatives to improve access to healthcare services |
4.2.4 Rising awareness about health and wellness |
4.2.5 Technological advancements in the pharmaceutical industry |
4.3 Market Restraints |
4.3.1 Stringent regulatory approval processes for prescription drugs |
4.3.2 Price control regulations impacting profit margins for drug manufacturers |
4.3.3 Increasing competition in the market leading to pricing pressures |
4.3.4 Lack of adequate healthcare infrastructure in rural areas |
4.3.5 Counterfeit drugs affecting market credibility and patient safety |
5 India Prescription Drugs Market Trends |
6 India Prescription Drugs Market, By Types |
6.1 India Prescription Drugs Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 India Prescription Drugs Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 India Prescription Drugs Market Revenues & Volume, By Branded, 2021- 2031F |
6.1.4 India Prescription Drugs Market Revenues & Volume, By Generic, 2021- 2031F |
6.2 India Prescription Drugs Market, By Therapy Area |
6.2.1 Overview and Analysis |
6.2.2 India Prescription Drugs Market Revenues & Volume, By Immunology, 2021- 2031F |
6.2.3 India Prescription Drugs Market Revenues & Volume, By Ophthalmology, 2021- 2031F |
6.2.4 India Prescription Drugs Market Revenues & Volume, By Respiratory, 2021- 2031F |
6.2.5 India Prescription Drugs Market Revenues & Volume, By Dermatology, 2021- 2031F |
6.2.6 India Prescription Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.3 India Prescription Drugs Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 India Prescription Drugs Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 India Prescription Drugs Market Revenues & Volume, By Topical, 2021- 2031F |
6.3.4 India Prescription Drugs Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.5 India Prescription Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.4 India Prescription Drugs Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 India Prescription Drugs Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 India Prescription Drugs Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.4 India Prescription Drugs Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.5 India Prescription Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.5 India Prescription Drugs Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 India Prescription Drugs Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 India Prescription Drugs Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.5.4 India Prescription Drugs Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.5 India Prescription Drugs Market Revenues & Volume, By Others, 2021- 2031F |
7 India Prescription Drugs Market Import-Export Trade Statistics |
7.1 India Prescription Drugs Market Export to Major Countries |
7.2 India Prescription Drugs Market Imports from Major Countries |
8 India Prescription Drugs Market Key Performance Indicators |
8.1 Number of prescriptions filled for prescription drugs |
8.2 Average revenue per prescription |
8.3 Prescription drug adherence rates |
8.4 Percentage of population covered by health insurance |
8.5 Rate of adoption of innovative prescription drugs |
9 India Prescription Drugs Market - Opportunity Assessment |
9.1 India Prescription Drugs Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 India Prescription Drugs Market Opportunity Assessment, By Therapy Area, 2021 & 2031F |
9.3 India Prescription Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 India Prescription Drugs Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 India Prescription Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 India Prescription Drugs Market - Competitive Landscape |
10.1 India Prescription Drugs Market Revenue Share, By Companies, 2024 |
10.2 India Prescription Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here